[go: up one dir, main page]

Reed, 1997 - Google Patents

Bcl-2 family proteins in cancer: regulators of cell death involved in resistance to therapy

Reed, 1997

Document ID
844177945366763450
Author
Reed J
Publication year
Publication venue
Cell Cycle Regulation, New Horizons in Therapeutics

External Links

Snippet

Cell death is a physiological process that plays a critical role in the regulation of tissue homeostasis by ensuring that the rate at which new cells are produced in the body through cell division is offset by a commensurate rate of cell loss. The amount of cell death that …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Similar Documents

Publication Publication Date Title
Reed et al. Bcl‐2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
Kuribayashi et al. Regulation of programmed cell death by the p53 pathway
Hale et al. Apoptosis: molecular regulation of cell death
US8614192B2 (en) Method for treating ocular cancer
Li et al. IL-7 promotes T cell proliferation through destabilization of p27Kip1
ES2294796T3 (en) MODULATORS OF THE FACTOR ASSOCIATED WITH THE TNF RECEIVER (TRAF), ITS PREPARATION AND USE.
EP1343884A2 (en) Jfy1 protein induces rapid apoptosis
Ookawa et al. Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line
US20030077262A1 (en) Methods and compositions for modulating apoptosis
Teng Protooncogenes as mediators of apoptosis
AU6165598A (en) Bak promotor expression system
US7223733B2 (en) Modulation of TRIP-Br function and method of treating proliferative disorders
Reed Bcl-2 family proteins in cancer: regulators of cell death involved in resistance to therapy
US7429648B1 (en) IREN protein, its preparation and use
KR20050107527A (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
Möröy et al. Regulators of life and death: the bcl-2 gene family
JP4252446B2 (en) Hepatitis protection mediated by ABIN
EP1366773A1 (en) Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
Samali et al. Role of Bcr-Abl kinase in resistance to apoptosis
KR100693677B1 (en) TN / NWF receptor family and functional regulators of other protein receptors
Guicciardi et al. The Fas/FasL Signaling Pathway
Gottlieb Probing the involvement of p53 in apoptosis using in vitro and in vivo models
McCarthy et al. Genes involved in apoptosis
Lin NF-kappa B and the regulation of sindbis virus-induced apoptosis
Hofmann Studies on the mechanisms of interferon/retinoid induced cell death